Effects of folic acid fortification on spina bifida prevalence in Brazil

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 91, Issue 9, 2011, Pages 831-835

  Orioli, Iêda Maria ^a,b   Lima do Nascimento, Ricardo ^a,b   López Camelo, Jorge Santiago ^b,c   Castilla, Eduardo Enrique ^b,c,d  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Instituto Nacional de Ciência e Tecnologia Genética Médica Populacional INAGEMP   (Brazil)

^c CEMIC   (Argentina)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Congenital defect; Folic acid; Food fortification; Neural tube defect; SINASC; Spina bifida

Indexed keywords

FOLIC ACID;

ARTICLE; BRAZIL; CROSS-SECTIONAL STUDY; DIET SUPPLEMENTATION; HEALTH PROGRAM; HUMAN; MAIZE; MANTEL HAENSZEL TEST; PREVALENCE; PRIORITY JOURNAL; SPINA BIFIDA; WHEAT;

BRAZIL; CROSS-SECTIONAL STUDIES; FEMALE; FOLIC ACID; FOOD, FORTIFIED; HUMANS; PREVALENCE; SPINAL DYSRAPHISM;

TRITICUM AESTIVUM; ZEA MAYS;

EID: 80052557363     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20830     Document Type: Article

References (28)

1. Agência Nacional de Vigilância Sanitária. 2002. Resolução RDC n°. 344, de 13 de dezembro de 2002. Diário Oficial da União. 18 dez.
2. Armitage P, Berry G. 1994. Statistical Method in Medical Research. 3rd ed. London: Blackwell Scientific. p 402-447.
3. Berry RJ, Bailey L, Mulinare J, Bower C;Folic Acid Working Group. 2010. Fortification of flour with folic acid. Food Nutr Bull 31(1 Suppl): S22-S35.
4. Botto LD, Lisi A, Bower C, et al. 2006. Trends of selected malformations in relation to folic acid recommendations and fortification: An international assessment. Birth Defects Res A Clin Mol Teratol 76: 693-705.
5. Calvo EB, Biglieri A. 2008. Impact of folic acid fortification on women nutritional status and on the prevalence of neural tube defects (Spanish). Arch Argent Pediatr 106: 492-498.
6. Castilla EE, Orioli IM. 1985. Epidemiology of neural tube defects in South America. Am J Med Genet 22: 695-702.
7. Castilla EE, Orioli IM. 2004. ECLAMC: The Latin American collaborative study of congenital malformations. Comm Genet 7: 76-94.
8. De Wals P, Tairou F, Van Allen MI, et al. 2007. Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med 357: 135-142.
9. Eichholzer M, Tönz O, Zimmermann R. 2006. Folic acid: a public-health challenge. Lancet 367: 1352-1361.
10. Elwood JM, Elwood JH. 1980. Epidemiology of anencephalus and spina bifida. Oxford: Oxford University Press.
11. EUROCAT Working Group. 1991. Prevalence of neural tube defects in 20 regions of Europe and the impact of prenatal diagnosis, 1980-1986. JEpidemiol Comm Hlth 45: 52-58.
12. Ferreira AFS, Giugliani R. 2008. Consumption of folic acid-fortified flour and folate-rich foods among women at reproductive age in South Brazil. Comm Genet 11: 179-184.
13. Freire WB, Hertrampf E, Cortés F. 2000. Effect of folic acid fortification in Chile: preliminary results. Eur J Pediatr Surg 10( Suppl 1): 42-43.
14. Gucciardi E, Pietrusiak MA, Reynolds DL, et al. 2002. Incidence of neural tube defects in Ontario, 1986-1999. CMAJ 167: 237-240.
15. Hertrampf E, Cortés F, Erickson JD, et al. 2003. Consumption of folic acid-fortified bread improves folate status in women of reproductive age in Chile. J Nutr 133: 3166-3169.
16. Honein MA, Paulozzi LJ, Mathews TJ, et al. 2001. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. J Am Med Assoc 285: 2981-2986.
17. Leoncini E, Mastroiacovo P. 2009. Systematic review of efficacy of folic acid fortification to decrease the prevalence of neural tube defects. Rome: Alessandra Lisi International Centre on Birth Defects.
18. López-Camelo JS, Castilla EE, Orioli IM. 2010. Folic acid flour fortification: impact on the frequencies of 52 congenital anomaly types in three South American countries. Am J Med Genet 152A: 2448-2458.
19. López-Camelo JS, Orioli IM, Dutra MG, et al. 2005. Reduction of birth prevalence rates of neural tube defects after folic acid fortification in Chile. Am J Med Genet 135A: 120-125.
20. Luquetti DV, Koifman RJ. 2009. Quality of reporting on birth defects in birth certificates: case study from a Brazilian reference hospital. Cad Saude Publica 25: 1721-1731.
21. Ministério da Saúde. 2009. Sistema de Informação sobre nascidos Vivos/Notas Técnicas. Available at:. Accessed March 18, 2009.
22. Nazer-H J, López Camelo JS, Castilla EE. 2001. ECLAMC: Estudio de 30 años de vigilancia epidemiológica de defectos de tubo neural en Chile y en Latino América. Rev Med Chile (Santiago) 129: 531-539.
23. Pacheco SS, Braga C, de Souza AI, et al. 2009. Effects of folic acid fortification on the prevalence of neural tube defects. Rev Saude Publica 43: 565-571.
24. Persad VL, Van den Hof MC, Dube JM, et al. 2002. Incidence of open neural tube defects in Nova Scotia after folic acid fortification. CMAJ 167: 241-245.
25. Santos LM, Pereira MZ. 2007. The effect of folic acid fortification on the reduction of neural tube defects. Cad Saude Publica 23: 17-24.
26. Sayed AR, Bourne D, Pattinson R, et al. 2008. Decline in the prevalence of neural tube defects following folic acid fortification and its cost-benefit in South Africa. Birth Defects Res A Clin Mol Teratol 82: 211-216.
27. Williams LJ, Mai CT, Edmonds LD, et al. 2002. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology 66: 33-39.
28. Zabala R, Waisman I, Corelli M, et al. 2008. Folic acid for neural tube defects prevention: consumption and information in fertile-age women in Centro Cuyo Region (Spanish). Arch Argent Pediatr 106: 295-301.